Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Return on Equity (2022 - 2025)

Cardio Diagnostics Holdings' Return on Equity history spans 4 years, with the latest figure at 0.73% for Q3 2025.

  • For Q3 2025, Return on Equity rose 171.0% year-over-year to 0.73%; the TTM value through Sep 2025 reached 0.73%, up 171.0%, while the annual FY2024 figure was 1.34%, 97.0% up from the prior year.
  • Return on Equity for Q3 2025 was 0.73% at Cardio Diagnostics Holdings, down from 0.59% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.11% in Q3 2022 and bottomed at 3.84% in Q1 2024.
  • The 4-year median for Return on Equity is 1.05% (2023), against an average of 1.58%.
  • The largest annual shift saw Return on Equity tumbled -349bps in 2023 before it skyrocketed 328bps in 2025.
  • A 4-year view of Return on Equity shows it stood at 0.48% in 2022, then plummeted by -570bps to 3.19% in 2023, then skyrocketed by 60bps to 1.27% in 2024, then skyrocketed by 42bps to 0.73% in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Return on Equity are 0.73% (Q3 2025), 0.59% (Q2 2025), and 0.56% (Q1 2025).